welcomeThe King's Thrombosis Centre is a leading multidisciplinary clinical and research group dedicated to the diagnosis and treatment of hypercoagulable conditions. We are a designated Haemophilia Centre and were the first National Venous Thromboembolism (VTE) Exemplar Centre, reflecting our national leadership in the prevention and treatment of VTE. Our clinical trials unit works in partnership with industry to develop new treatments for VTE prevention and treatment.



The FIRST Registry

With the next generation of oral anticoagulants entering clinical practice, the FIRST registry will provide an important data tool to increase knowledge and improve the quality of care of patients with VTE. Read more...

Exemplar Centre Network website


The Exemplar Centre Network website has moved. After being hosted at the King's Thrombosis Centre website since its launch in 2007, the website will now be managed as part of the National VTE prevention Programme and can be accessed by clicking here.

Latest News

  • Anticoagulation news items. Week commencing 22nd June 2015
    High-dose ibuprofen (≥2400mg/day): small increase in cardiovascular risk Medicines and Healthcare products Regulatory Agency EU review confirms that CV risk of high-dose ibuprofen (≥2400mg/day) is similar to COX 2 inhibitors…
  • Anticoagulation news items. Week commencing 15th June 2015
    Thromboembolic Complications and Prophylaxis Patterns in Colorectal Surgery JAMA Surgery US study of 16,120 patients who had undergone colorectal surgery found venous thromboembolism rates are low and largely unchanged despite…
  • Anticoagulation news items. Week commencing 8th June 2015
    Guideline on aspects of cancer-related venous thrombosis British Committee for Standards in Haematology This aims to provide healthcare professionals with clear guidance on prevention and management of venous thromboembolism (VTE)…